company background image
3737 logo

Zhongzhi Pharmaceutical Holdings SEHK:3737 Stok Raporu

Son Fiyat

HK$1.08

Piyasa Değeri

HK$932.7m

7D

6.9%

1Y

-16.9%

Güncellenmiş

02 Oct, 2024

Veri

Şirket Finansalları

Zhongzhi Pharmaceutical Holdings Limited

SEHK:3737 Stok Raporu

Piyasa değeri: HK$932.7m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

3737 Stoklara Genel Bakış

Bir yatırım holding şirketi olan Zhongzhi Pharmaceutical Holdings Limited, Çin Halk Cumhuriyeti'nde farmasötik ürünlerin araştırılması, geliştirilmesi, üretimi ve satışı ile ilgilenmektedir.

Zhongzhi Pharmaceutical Holdings Limited Rakipler

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Zhongzhi Pharmaceutical Holdings
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıHK$1.08
52 Haftanın En Yüksek SeviyesiHK$1.56
52 Haftanın En Düşük SeviyesiHK$0.82
Beta0.48
11 Aylık Değişim13.68%
3 Aylık Değişim-13.60%
1 Yıllık Değişim-16.92%
33 Yıllık Değişim-6.09%
5 Yıllık Değişim-23.94%
Halka arzdan bu yana değişim-54.81%

Son Haberler & Güncellemeler

Little Excitement Around Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Earnings As Shares Take 26% Pounding

Aug 22
Little Excitement Around Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Earnings As Shares Take 26% Pounding

Recent updates

Little Excitement Around Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Earnings As Shares Take 26% Pounding

Aug 22
Little Excitement Around Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Earnings As Shares Take 26% Pounding

Calculating The Intrinsic Value Of Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

Jun 19
Calculating The Intrinsic Value Of Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

Most Shareholders Will Probably Agree With Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) CEO Compensation

May 10
Most Shareholders Will Probably Agree With Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) CEO Compensation

Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

May 05
Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Apr 21
Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Prospects Need A Boost To Lift Shares

Feb 01
Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Prospects Need A Boost To Lift Shares

These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

May 24
These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?

Aug 26
Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?

Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet

Apr 28
Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet

These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

Jun 11
These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

Investors Met With Slowing Returns on Capital At Zhongzhi Pharmaceutical Holdings (HKG:3737)

May 06
Investors Met With Slowing Returns on Capital At Zhongzhi Pharmaceutical Holdings (HKG:3737)

Zhongzhi Pharmaceutical Holdings (HKG:3737) Strong Profits May Be Masking Some Underlying Issues

Apr 21
Zhongzhi Pharmaceutical Holdings (HKG:3737) Strong Profits May Be Masking Some Underlying Issues

Do Zhongzhi Pharmaceutical Holdings's (HKG:3737) Earnings Warrant Your Attention?

Mar 29
Do Zhongzhi Pharmaceutical Holdings's (HKG:3737) Earnings Warrant Your Attention?

The Zhongzhi Pharmaceutical Holdings (HKG:3737) Share Price Has Gained 50% And Shareholders Are Hoping For More

Mar 05
The Zhongzhi Pharmaceutical Holdings (HKG:3737) Share Price Has Gained 50% And Shareholders Are Hoping For More

Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

Feb 15
Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

What Is The Ownership Structure Like For Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)?

Jan 14
What Is The Ownership Structure Like For Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)?

Would Zhongzhi Pharmaceutical Holdings Limited (HKG:3737) Be Valuable To Income Investors?

Dec 27
Would Zhongzhi Pharmaceutical Holdings Limited (HKG:3737) Be Valuable To Income Investors?

If You Like EPS Growth Then Check Out Zhongzhi Pharmaceutical Holdings (HKG:3737) Before It's Too Late

Dec 14
If You Like EPS Growth Then Check Out Zhongzhi Pharmaceutical Holdings (HKG:3737) Before It's Too Late

Did You Miss Zhongzhi Pharmaceutical Holdings' (HKG:3737) 31% Share Price Gain?

Nov 30
Did You Miss Zhongzhi Pharmaceutical Holdings' (HKG:3737) 31% Share Price Gain?

Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

Nov 17
Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

Hissedar Getirileri

3737HK PharmaceuticalsHK Pazar
7D6.9%10.8%8.7%
1Y-16.9%26.7%19.7%

Getiri vs. Endüstri: 3737 geçen yıl % 26.7 oranında getiri sağlayan Hong Kong Pharmaceuticals sektörünün gerisinde kaldı.

Getiri vs Piyasa: 3737 geçen yıl % 19.7 oranında getiri sağlayan Hong Kong Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is 3737's price volatile compared to industry and market?
3737 volatility
3737 Average Weekly Movement7.5%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement7.1%
10% most volatile stocks in HK Market14.7%
10% least volatile stocks in HK Market3.6%

İstikrarlı Hisse Senedi Fiyatı: 3737 son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: 3737 'nin haftalık oynaklığı ( 7% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
19932,736Ying Feng Laiwww.zeus.cn

Bir yatırım holding şirketi olan Zhongzhi Pharmaceutical Holdings Limited, Çin Halk Cumhuriyeti'nde farmasötik ürünlerin araştırılması, geliştirilmesi, üretimi ve satışı ile ilgilenmektedir. Şirket, İlaç Üretimi ve Zincir Eczanelerin İşletilmesi segmentleri aracılığıyla faaliyet göstermektedir. Zeus, Liumian ve Caojinghua markaları altında Çin patentli ilaçlar ve kaynatma parçaları sağlamaktadır.

Zhongzhi Pharmaceutical Holdings Limited Temel Bilgiler Özeti

Zhongzhi Pharmaceutical Holdings'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
3737 temel i̇stati̇sti̇kler
Piyasa değeriHK$932.69m
Kazançlar(TTM)HK$122.80m
Gelir(TTM)HK$2.25b

7.6x

F/K Oranı

0.4x

P/S Oranı

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
3737 gelir tablosu (TTM)
GelirCN¥2.04b
Gelir MaliyetiCN¥877.22m
Brüt KârCN¥1.17b
Diğer GiderlerCN¥1.06b
KazançlarCN¥111.32m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)0.13
Brüt Marj57.08%
Net Kâr Marjı5.45%
Borç/Özkaynak Oranı6.7%

3737 uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün